Shugeng Gao

6.3k total citations · 1 hit paper
127 papers, 2.5k citations indexed

About

Shugeng Gao is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, Shugeng Gao has authored 127 papers receiving a total of 2.5k indexed citations (citations by other indexed papers that have themselves been cited), including 79 papers in Pulmonary and Respiratory Medicine, 53 papers in Oncology and 35 papers in Surgery. Recurrent topics in Shugeng Gao's work include Lung Cancer Diagnosis and Treatment (43 papers), Lung Cancer Treatments and Mutations (36 papers) and Cancer Immunotherapy and Biomarkers (23 papers). Shugeng Gao is often cited by papers focused on Lung Cancer Diagnosis and Treatment (43 papers), Lung Cancer Treatments and Mutations (36 papers) and Cancer Immunotherapy and Biomarkers (23 papers). Shugeng Gao collaborates with scholars based in China, United States and Japan. Shugeng Gao's co-authors include Qi Xue, Jie He, Yousheng Mao, Fengwei Tan, Wei Guo, Yushun Gao, Jianming Ying, Peng Song, Bolun Zhou and Juwei Mu and has published in prestigious journals such as New England Journal of Medicine, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Shugeng Gao

117 papers receiving 2.5k citations

Hit Papers

Perioperative Pembrolizumab for Early-Stage Non–Small-Cel... 2023 2026 2024 2025 2023 100 200 300 400

Peers

Shugeng Gao
Shugeng Gao
Citations per year, relative to Shugeng Gao Shugeng Gao (= 1×) peers Isabelle Rouquette

Countries citing papers authored by Shugeng Gao

Since Specialization
Citations

This map shows the geographic impact of Shugeng Gao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shugeng Gao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shugeng Gao more than expected).

Fields of papers citing papers by Shugeng Gao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shugeng Gao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shugeng Gao. The network helps show where Shugeng Gao may publish in the future.

Co-authorship network of co-authors of Shugeng Gao

This figure shows the co-authorship network connecting the top 25 collaborators of Shugeng Gao. A scholar is included among the top collaborators of Shugeng Gao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shugeng Gao. Shugeng Gao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Gao, Shugeng, et al.. (2025). In-situ observation and simulation of melt pool evolution and single-track formation in laser cladding. Journal of Materials Research and Technology. 39. 5986–6000.
2.
Garassino, Marina Chiara, Heather A. Wakelee, Jonathan Spicer, et al.. (2024). Health-related quality of life (HRQoL) outcomes from the randomized, double-blind phase 3 KEYNOTE-671 study of perioperative pembrolizumab for early-stage non-small-cell lung cancer (NSCLC).. Journal of Clinical Oncology. 42(16_suppl). 8012–8012. 2 indexed citations
4.
Yang, Zhenlin, He Tian, Bozhao Li, et al.. (2024). Single-cell sequencing reveals immune features of treatment response to neoadjuvant immunochemotherapy in esophageal squamous cell carcinoma. Nature Communications. 15(1). 9097–9097. 25 indexed citations
5.
Zhou, Bolun, Ruochuan Zang, Peng Song, et al.. (2023). Association between radiotherapy and risk of second primary malignancies in patients with resectable lung cancer: a population-based study. Journal of Translational Medicine. 21(1). 10–10. 13 indexed citations
6.
Chen, Xiaowei, Guangyu Bai, Ruochuan Zang, et al.. (2023). Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer. Translational Oncology. 35. 101725–101725. 6 indexed citations
7.
Song, Peng, Wenbin Li, Zhirong Qian, et al.. (2022). Integrated analysis of single-cell and bulk RNA-sequencing identifies a signature based on B cell marker genes to predict prognosis and immunotherapy response in lung adenocarcinoma. Cancer Immunology Immunotherapy. 71(10). 2341–2354. 34 indexed citations
8.
Zhou, Bolun, Ruochuan Zang, Moyan Zhang, et al.. (2022). Worldwide burden and epidemiological trends of tracheal, bronchus, and lung cancer: A population-based study. EBioMedicine. 78. 103951–103951. 50 indexed citations
9.
Wang, Shuhang, Beibei Mao, Ning Li, et al.. (2022). Genomic features and tumor immune microenvironment alteration in NSCLC treated with neoadjuvant PD-1 blockade. npj Precision Oncology. 6(1). 2–2. 21 indexed citations
10.
Guo, Wei, Xin Chen, Rui Liu, et al.. (2022). Sensitive detection of stage I lung adenocarcinoma using plasma cell-free DNA breakpoint motif profiling. EBioMedicine. 81. 104131–104131. 32 indexed citations
11.
Zhou, Bolun, Fenglong Bie, Ruochuan Zang, et al.. (2022). RNA modification writer expression profiles predict clinical outcomes and guide neoadjuvant immunotherapy in non-small cell lung cancer. EBioMedicine. 84. 104268–104268. 30 indexed citations
12.
Guo, Wei, Bolun Zhou, Zhenlin Yang, et al.. (2022). Integrating microarray-based spatial transcriptomics and single-cell RNA-sequencing reveals tissue architecture in esophageal squamous cell carcinoma. EBioMedicine. 84. 104281–104281. 44 indexed citations
13.
Zhang, Zhihui, Yuejun Luo, Chaoqi Zhang, et al.. (2021). An immune-related lncRNA signature predicts prognosis and adjuvant chemotherapeutic response in patients with small-cell lung cancer. Cancer Cell International. 21(1). 6 indexed citations
14.
Zhou, Bolun & Shugeng Gao. (2021). Construction and validation of a novel immune and tumor mutation burden-based prognostic model in lung adenocarcinoma. Cancer Immunology Immunotherapy. 71(5). 1183–1197. 8 indexed citations
15.
Bie, Fenglong, Nan Sun, Ruochuan Zang, et al.. (2021). Comprehensive analysis of PD-L1 expression, tumor-infiltrating lymphocytes, and tumor microenvironment in LUAD: differences between Asians and Caucasians. Clinical Epigenetics. 13(1). 229–229. 11 indexed citations
16.
Li, Jiagen, Qi Xue, Yushun Gao, et al.. (2021). Uniportal video‐assisted thoracoscopic left pneumonectomy: Retrospective analysis of eighteen consecutive patients from a single center. Thoracic Cancer. 12(3). 324–328. 1 indexed citations
19.
Li, Jiagen, Bin Qiu, Marco Scarci, Gaetano Rocco, & Shugeng Gao. (2019). Uniportal video‐assisted thoracic surgery could reduce postoperative thorax drainage for lung cancer patients. Thoracic Cancer. 10(6). 1334–1339. 13 indexed citations
20.
Li, Ning, Fengwei Tan, Bin Qiu, et al.. (2018). [Comparison of lung cancer surgery in China, 2005 vs. 2015].. PubMed. 40(4). 300–302. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026